Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| GRAPHIC PACKAGING HOLDING COGPK · Entity 4188 | Director | May 08, 2026 | May 11, 2026 |
| RYDER SYSTEM INCR · Entity 3563 | Director | May 01, 2026 | May 05, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
GRAPHIC PACKAGING HOLDING CO
Report date May 08, 2026 · Filed May 11, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 97,569 |
Reported balance
After 2026-05-08 transaction · row 1
1 source rowRow 1 · 2026-05-08 · Purchase · Acquired 14,000 · Balance 97,569 F1: The 14,000 shares were purchased through a number of separate trades, with purchase prices ranging from $10.99 to $11.00, and a weighted average purchase price of $10.9994. The Reporting Person undertakes to provide, upon request by the Staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares purchased at each separate purchase price. |
Filing footnotes · ownership attribution and instrument terms
F1: The 14,000 shares were purchased through a number of separate trades, with purchase prices ranging from $10.99 to $11.00, and a weighted average purchase price of $10.9994. The Reporting Person undertakes to provide, upon request by the Staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares purchased at each separate purchase price.
RYDER SYSTEM INC
Report date May 01, 2026 · Filed May 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| common stockSEC Table I · non-derivative | Direct | 31,097 |
Ending reported balance
After 2026-05-01 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-05-01 · Grant · Acquired 720 · Balance 30,420 F1: Annual grant of $180,000 of restricted stock units pursuant to the Company's Amended and Restated 2019 Equity and Incentive Compensation Plan based on $249.99 per share, which was the last reported sale price of the Company's common stock on May 1, 2026. Row 2 · 2026-05-01 · Grant · Acquired 677 · Balance 31,097 F2: Grant of restricted stock units pursuant to the dividend reinvestment feature of the Issuer's Amended and Restated 2019 Equity and Incentive Compensation Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: Annual grant of $180,000 of restricted stock units pursuant to the Company's Amended and Restated 2019 Equity and Incentive Compensation Plan based on $249.99 per share, which was the last reported sale price of the Company's common stock on May 1, 2026.
F2: Grant of restricted stock units pursuant to the dividend reinvestment feature of the Issuer's Amended and Restated 2019 Equity and Incentive Compensation Plan.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
ZIMMER BIOMET HOLDINGS, INC.
Report date September 30, 2026 · Filed October 03, 2026
Section 16 reporting ended · disclosed 2019-04-02. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Phantom Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $89.85 | Direct | 33,660.84 |
Reported balance
After 2026-09-30 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-09-30 · Grant · Acquired 306.066 · Balance 33,660.84 F1: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3: Units are to be settled in cash in five annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F4: Includes 85.331 phantom stock units accrued on July 31, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. |
Filing footnotes · ownership attribution and instrument terms
F1: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
F2: The Conversion or Exercise Price of Derivative Security is 1-for-1.
F3: Units are to be settled in cash in five annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.
F4: Includes 85.331 phantom stock units accrued on July 31, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 15, 2018 Filed May 17, 2018 18:14 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantPhantom Stock Units · Derivative | 500 | $0.00 Strike: $113.72 | $0.00 |
DisclosureSEC source: 0000911916-18-000124 · edgar.xml · derivative · entry 1 HAGEMANN ROBERT · CIK 0001222676 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,196.571 Underlying: Common Stock · 500 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director ("Annual Deferred Share Units"). F3 · derivative.expiration_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director ("Annual Deferred Share Units"). F4 · balance_after: Includes 33.848 phantom stock units accrued on April 30, 2018 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| May 04, 2018 Filed May 7, 2018 20:15 UTC | RYDER SYSTEM INC R · Entity 3563 | Grantcommon stock | 1,990 | $0.00 | $0.00 |
DisclosureSEC source: 0000085961-18-000094 · wf-form4_152572408139813.xml · nonDerivative · entry 1 HAGEMANN ROBERT · CIK 0001222676 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,766 F1 · kind: Annual grant of $135,000 of restricted stock units pursuant to the Company's Amended and Restated 2012 Equity and Incentive Compensation Plan based on $67.83 per share which was the last reported sale price of the Company's common stock on May 4, 2018. Read SEC document |
| March 31, 2018 Filed Apr 3, 2018 19:10 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantPhantom Stock Units · Derivative | 264.708 | $0.00 Strike: $108.61 | $0.00 |
DisclosureSEC source: 0000911916-18-000106 · edgar.xml · derivative · entry 1 HAGEMANN ROBERT · CIK 0001222676 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,662.723 Underlying: Common Stock · 264.708 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in seven annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F3 · derivative.expiration_date: Units are to be settled in cash in seven annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F4 · balance_after: Includes 30.292 phantom stock units accrued on January 29, 2018 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| December 31, 2017 Filed Jan 3, 2018 18:30 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantPhantom Stock Units · Derivative | 237.036 | $0.00 Strike: $121.29 | $0.00 |
DisclosureSEC source: 0000911916-18-000015 · edgar.xml · derivative · entry 1 HAGEMANN ROBERT · CIK 0001222676 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,367.723 Underlying: Common Stock · 237.036 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F3 · derivative.expiration_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F4 · balance_after: Includes 31.444 phantom stock units accrued on October 27, 2017 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| December 15, 2017 Filed Dec 19, 2017 23:57 UTC | RYDER SYSTEM INC R · Entity 3563 | Grantcommon stock | 119 | $0.00 | $0.00 |
DisclosureSEC source: 0000085961-17-000127 · wf-form4_151372783169086.xml · nonDerivative · entry 1 HAGEMANN ROBERT · CIK 0001222676 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,776 F1 · kind: Grant of restricted stock units pursuant to the dividend reinvestment feature of the Issuer's 2012 Amended and Restated Equity and Incentive Compensation Plan. Read SEC document |
| September 30, 2017 Filed Oct 3, 2017 12:55 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantPhantom Stock Units · Derivative | 247.269 | $0.00 Strike: $116.27 | $0.00 |
DisclosureSEC source: 0000911916-17-000235 · edgar.xml · derivative · entry 1 HAGEMANN ROBERT · CIK 0001222676 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,099.243 Underlying: Common Stock · 247.269 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F3 · derivative.expiration_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F4 · balance_after: Includes 30.543 phantom stock units accrued on July 28, 2017 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| June 30, 2017 Filed Jul 5, 2017 19:52 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantPhantom Stock Units · Derivative | 208.317 | $0.00 Strike: $128.41 | $0.00 |
DisclosureSEC source: 0000911916-17-000212 · edgar.xml · derivative · entry 1 HAGEMANN ROBERT · CIK 0001222676 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,821.431 Underlying: Common Stock · 208.317 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F3 · derivative.expiration_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. Read SEC document |
| May 24, 2017 Filed May 25, 2017 18:46 UTC | GRAPHIC PACKAGING HOLDING CO GPK · Entity 4188 | GrantCommon Stock | 8,190 | $13.43 | $109,991.70 |
DisclosureSEC source: 0001209191-17-035284 · doc4.xml · nonDerivative · entry 1 HAGEMANN ROBERT · CIK 0001222676 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,011 Read SEC document |
| May 12, 2017 Filed May 16, 2017 18:12 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantRestricted Stock Units · Derivative | 1,067.85 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-17-000173 · edgar.xml · derivative · entry 2 HAGEMANN ROBERT · CIK 0001222676 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,178.577 Underlying: Common Stock · 1,067.85 shares Expires not disclosed F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F5 · derivative.exercise_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F5 · derivative.expiration_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F6 · balance_after: Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods. Read SEC document |
| May 12, 2017 Filed May 16, 2017 18:12 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantPhantom Stock Units · Derivative | 500 | $0.00 Strike: $121.74 | $0.00 |
DisclosureSEC source: 0000911916-17-000173 · edgar.xml · derivative · entry 1 HAGEMANN ROBERT · CIK 0001222676 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,613.114 Underlying: Common Stock · 500 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director ("Annual Deferred Share Units"). F3 · derivative.expiration_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director ("Annual Deferred Share Units"). F4 · balance_after: Includes 30.555 phantom stock units accrued on April 28, 2017 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| May 05, 2017 Filed May 9, 2017 21:36 UTC | RYDER SYSTEM INC R · Entity 3563 | Grantcommon stock | 1,965 | $0.00 | $0.00 |
DisclosureSEC source: 0000085961-17-000054 · wf-form4_149436575195759.xml · nonDerivative · entry 1 HAGEMANN ROBERT · CIK 0001222676 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,657 F1 · kind: Annual grant of $135,000 of restricted stock units pursuant to the Company's Amended and Restated 2012 Equity and Incentive Compensation Plan based on $68.70 per share which was the last reported sale price of the Company's common stock on May 5, 2017. Read SEC document |
| March 31, 2017 Filed Apr 4, 2017 19:11 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantPhantom Stock Units · Derivative | 220.182 | $0.00 Strike: $121.49 | $0.00 |
DisclosureSEC source: 0000911916-17-000149 · edgar.xml · derivative · entry 1 HAGEMANN ROBERT · CIK 0001222676 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,082.559 Underlying: Common Stock · 220.182 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F3 · derivative.expiration_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F4 · balance_after: Includes 29.982 phantom stock units accrued on January 27, 2017 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| December 31, 2016 Filed Jan 4, 2017 20:50 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantPhantom Stock Units · Derivative | 258.729 | $0.00 Strike: $103.39 | $0.00 |
DisclosureSEC source: 0000911916-17-000012 · edgar.xml · derivative · entry 1 HAGEMANN ROBERT · CIK 0001222676 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,832.395 Underlying: Common Stock · 258.729 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F3 · derivative.expiration_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F4 · balance_after: Includes 28.170 phantom stock units accrued on October 28, 2016 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| December 16, 2016 Filed Dec 20, 2016 21:07 UTC | RYDER SYSTEM INC R · Entity 3563 | Grantcommon stock | 75 | $0.00 | $0.00 |
DisclosureSEC source: 0000085961-16-000172 · wf-form4_148226805941716.xml · nonDerivative · entry 1 HAGEMANN ROBERT · CIK 0001222676 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,692 F1 · kind: Grant of restricted stock units pursuant to the dividend reinvestment feature of the Issuer's 2012 Equity and Incentive Compensation Plan. Read SEC document |
| September 30, 2016 Filed Oct 4, 2016 20:23 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantPhantom Stock Units · Derivative | 206.771 | $0.00 Strike: $129.37 | $0.00 |
DisclosureSEC source: 0000911916-16-000670 · edgar.xml · derivative · entry 1 HAGEMANN ROBERT · CIK 0001222676 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,545.496 Underlying: Common Stock · 206.771 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F3 · derivative.expiration_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F4 · balance_after: Includes 26.131 phantom stock units accrued on July 29, 2016 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.